CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back.
about
Evaluation of bone marrow mononuclear cells as an adjunct therapy to minced muscle graft for the treatment of volumetric muscle loss injuries.Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networImmune restoration following hematopoietic stem cell transplantation: an evolving target.Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell tThe road to purified hematopoietic stem cell transplants is paved with antibodies.Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients.
P2860
Q33784964-D6B5B2D4-2B06-4B17-AD62-AFAC4AE2833DQ35148420-5BF8FC95-AB78-4DA0-AB8D-1F221D4597F7Q36075296-2829D6F9-5FB7-489C-9C5A-EA35E6F87D96Q36212392-5FA8AF8A-5E08-4858-8653-B4389FBC637CQ38039703-C21ED86E-AE7F-4B4B-B855-9A7F8171282EQ40177200-9564B1AE-F914-4152-9EFF-A15FA491980BQ46509828-E5049052-6F62-4D31-B993-38EFDEE98342Q51637388-F504F6DA-6A5F-4237-99C6-C5D5FE519EC9
P2860
CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
CD34+-enriched peripheral bloo ...... ite donor lymphocyte add-back.
@en
CD34+-enriched peripheral bloo ...... ite donor lymphocyte add-back.
@nl
type
label
CD34+-enriched peripheral bloo ...... ite donor lymphocyte add-back.
@en
CD34+-enriched peripheral bloo ...... ite donor lymphocyte add-back.
@nl
prefLabel
CD34+-enriched peripheral bloo ...... ite donor lymphocyte add-back.
@en
CD34+-enriched peripheral bloo ...... ite donor lymphocyte add-back.
@nl
P2860
P50
P1476
CD34+-enriched peripheral bloo ...... ite donor lymphocyte add-back.
@en
P2093
Catrin Theuser
P2860
P304
P356
10.1046/J.1365-2141.2002.03731.X
P407
P577
2002-09-01T00:00:00Z